SC 13G
BIOXCEL THERAPEUTICS, INC.
- Company
- BioXcel Therapeutics, Inc.
- Filed
- February 2, 2023
- Accession Number
- 0000902664-23-001140
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →